Advertisement
Screener

ENANTA PHARMACEUTICALS, INC (ENTA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ENANTA PHARMACEUTICALS, INC Cash Flow Breakdown

Cash flow breakdown shows where ENANTA PHARMACEUTICALS, INC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-09-30: from running the business, $19.27M went out.
  • Fiscal year ended 2025-09-30: from investing, $40.35M came in.
  • Fiscal year ended 2025-09-30: from financing, $26.62M went out.
  • Fiscal year ended 2025-09-30: change in cash, $5.54M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldOtherNot split outChange in cash
2025-09-30-$19.27M$40.35M-$277.00K$145.00K-$26.49M*-$5.54M
2024-09-30-$78.76M$58.23M-$294.00K$147.00K-$27.48M*-$48.16M
2023-09-30-$103.15M-$53.58M-$3.76M$2.21M$199.68M*$41.39M
2022-09-30-$84.78M$54.90M-$1.23M$21.26M-$9.85M
2021-09-30-$70.00M$36.99M-$534.00K$3.61M-$29.93M
2020-09-30$7.09M$19.83M-$1.50M$10.48M$35.90M
2019-09-30$71.42M-$86.66M-$4.19M$6.85M-$12.67M
2018-09-30$29.22M-$35.40M-$1.76M$6.24M-$1.77M
2017-09-30$52.65M-$4.57M-$202.00K$1.08M$213.00K$49.10M
2016-09-30$35.81M-$43.66M$1.03M$1.75M-$5.15M
2015-09-30$76.67M-$88.19M$726.00K$1.81M-$8.97M
2014-09-30$20.18M$497.00K$1.05M$110.00K$21.84M
2013-09-30$10.65M-$69.22M$559.00K$56.35M*-$1.65M
2012-09-30$22.62M-$18.04M$141.00K-$1.05M*$3.67M
2011-09-30$24.02M-$17.68M$34.00K$6.37M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$9.97M*$14.01M*$0.00*$492.00K*-$6.03M*
2026-03-31-$7.16M*$11.94M*-$305.00K*$49.00K*-$7.04M*
2025-12-31-$11.70M-$47.30M-$97.00K$141.00K$64.09M*$5.14M
2025-09-30-$6.49M*$2.30M*-$10.00K*$51.00K*-$8.36M*
2025-06-30$17.51M*-$26.48M*-$3.00K*$0.00*-$6.42M*
2025-03-31-$13.49M*-$4.37M*-$127.00K*$0.00*-$6.76M*
2024-12-31-$16.80M$68.90M-$137.00K$94.00K-$4.94M*$47.12M
2024-09-30-$10.40M*$19.07M*-$19.00K*$68.00K*-$7.26M*
2024-06-30-$14.78M*-$6.34M*$0.00*$28.00K*-$6.67M*
2024-03-31-$28.60M*$58.62M*-$92.00K*$51.00K*-$6.37M*
2023-12-31-$24.99M-$13.12M-$183.00K$0.00-$7.17M*-$45.45M
2023-09-30-$21.60M*$11.84M*-$23.00K*$0.00*
2023-06-30-$32.13M*-$145.75M*$0.00*$200.00K*$199.68M*
2023-03-31-$13.78M*$46.77M*-$2.91M*$882.00K*
2022-12-31-$35.64M$33.57M-$825.00K$1.13M-$1.77M
2022-09-30-$15.53M*$28.23M*-$1.00K*$2.93M*
2022-06-30-$29.60M*$16.22M*$0.00*$4.12M*
2022-03-31-$26.38M*-$35.05M*-$451.00K*$3.80M*
2021-12-31-$13.27M$45.50M-$777.00K$10.41M$41.86M
2021-09-30-$21.02M*$72.68M*$0.00*$943.00K*
2021-06-30-$29.51M*-$43.70M*$0.00*$686.00K*
2021-03-31-$4.58M*$25.46M*$0.00*$1.15M*
2020-12-31-$14.89M-$17.45M-$534.00K$833.00K-$32.04M
2020-09-30-$15.46M*$2.50M*$0.00*$233.00K*
2020-06-30-$4.49M*$26.78M*$0.00*$3.23M*
2020-03-31$14.67M*$27.75M*-$358.00K*$4.72M*
2019-12-31$12.36M-$37.20M-$1.14M$2.31M-$23.67M
2019-09-30$8.54M*-$52.21M*$0.00*$709.00K*
2019-06-30$2.53M*-$14.85M*$0.00*$512.00K*
2019-03-31$30.09M*$1.32M*$4.47M*
2018-12-31$30.25M-$20.93M$1.16M$10.46M
2018-09-30$28.34M*-$7.95M*$1.00K*$1.05M*$21.43M*
2018-06-30$4.05M*-$31.46M*$0.00*$2.98M*-$24.45M*
2018-03-31-$7.58M*$6.46M*$1.77M*-$1.13M*
2017-12-31$4.41M-$2.45M$436.00K$2.38M
2017-09-30$57.31M*-$14.90M*$0.00*$813.00K*$43.41M*
2017-06-30-$4.80M*$7.66M*$0.00*$208.00K*$3.05M*
2017-03-31-$3.00M*$1.81M*$9.00K*-$1.41M*
2016-12-31$3.15M$865.00K$49.00K$4.04M
2016-09-30-$2.13M*-$6.15M*$81.00K*-$2.00K*-$8.21M*
2016-06-30-$2.11M*-$31.43M*$284.00K*$1.70M*-$31.57M*
2016-03-31$10.05M*-$457.00K*$499.00K*$10.13M*
2015-12-31$29.99M-$5.63M$162.00K$24.51M
2015-09-30-$2.38M*$4.10M*$162.00K*-$3.00K*$1.88M*
2015-06-30-$14.20M*$8.17M*$224.00K*-$102.00K*-$5.91M*
2015-03-31$98.86M*-$107.48M*$245.00K*$0.00*-$8.38M*
2014-12-31-$5.61M$7.03M$95.00K$1.92M$3.43M
2014-09-30-$4.93M*$9.21M*$39.00K*$5.00K*$4.33M*
2014-06-30$35.11M*-$27.31M*$369.00K*$8.27M*
2014-03-31-$4.13M*$17.25M*$557.00K*$13.68M*
2013-12-31-$5.87M$1.35M$89.00K-$4.43M
2013-09-30-$2.50M*-$7.64M*$122.00K*-$10.02M*
2013-06-30-$5.92M*-$48.22M*$22.00K*-$1.47M*-$55.59M*
2013-03-31$10.03M*-$15.86M*$350.00K*$59.20M*$53.73M*
2012-12-31$9.04M$2.50M$65.00K-$1.39M*$10.22M
2012-09-30-$1.70M*$9.24M*$15.00K*-$1.01M*$6.55M*
2012-06-30-$3.83M*-$12.89M*$19.00K*-$16.74M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Rezolute, Inc. (RZLT)United States$0.382B-6.45
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63